Ledger.Open graph →
SEC Form D · filed December 23, 2025

Mediar Therapeutics, Inc

Offering
$75.7M
Sold
$37.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Maina Bhaman · Cambridge, MADirectorAllan Marchington · Boston, MADirectorRahul Ballal · CAMBRIDGE, MAExec · DirectorAndreas Jurgeit · Culver City, CADirectorBharat Srinivasa · Boston, MADirectorCassidy Blundell · Watertown, MADirectorAdam Cotton · Boston, MADirectorSimon Sturge · Boston, MADirectorMarie-Claire Peakman · New York, NYDirectorAndreas Jurgeit · Culver City, CADirectorBharat Srinivasa · Boston, MADirectorAllan Marchington · La Jolla, CADirectorRahul Ballal · CAMBRIDGE, MAExec · DirectorCassidy Blundell · Watertown, MADirectorMaina Bhaman · Cambridge, MADirectorAdam Cotton · Boston, MADirectorSimon Sturge · Boston, MADirectorMarie-Claire Peakman · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗